Abortion, Habitual
16
1
1
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
31%
5 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (16)
Potential Role of microRNA 410 and BIRC7 Pathways in Recurrent Spontaneous Miscarriage
Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History
LIGHT Trial: Levothyroxine for Gestational Hypothyroidism in Recurrent Pregnancy Loss
RPL: Interval to Live Birth and Adverse Perinatal Outcomes
Explore the Role of NLRP7 in the Regulation of Progestereone Induced Decidualization of Human Endometrial Stroma Cells
Nutritional Deficiencies About Recurrent Miscarriage
Effectiveness of Metformin in Recurrent Miscarriage in a Woman With Hyperinsulinaemia
Early Pregnancy Cohort and Preimplantation Factor
Intralipid for Recurrent Miscarriage
Effects of PGS in Infertile Female Patients With RPL
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
RECAB-ASA; Treatment of Recurrent Abortion With Aspirin
Pr-conceptional Progesterone for Unexplained Recurrent Miscarriage
Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss
Impact of Sperm DNA Integrity on In Vitro Cycles
Intravenous Immunoglobulin (IVIG) for Treatment of Unexplained Secondary Recurrent Miscarriage